Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

March 30, 2007 Notes: Pharmatek to Manufacture Oral HIV Medication for Aventrx, Eden to Provide Development and Manufacturing Services for ImmBio's Flu Vaccine Program, More

March 23, 2007 Notes: Cobra Joins Vaccine-Delivery Development Consortium, InterMune to Cut 50% of its Workforce, More

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Gurgaon, Haryana, India (Mar. 13)-Ranbaxy Laboratories Limited confirmed that it has made a nonbinding bid for the generic drug business of Merck KGaA.

Ranbaxy Makes Bid for Merck KGaA's Generic Drug Business

Just because the wheels are turning doesn't mean they're going forward.

Maintain Your Moving Parts

The book is written for drug-delivery scientists experienced in the dermatological or transdermal fields.

Getting under Our Skin: The Evolving Field of Transdermal Delivery

Washington, DC (Feb. 22)-The Biotechnology Industry Organization criticized two separate studies respectively released by the Pharmaceutical Care Management Association and Express Scripts, Inc. regarding the cost-savings, interchangeability, and market penetration of follow-on biologics.

BIO Raises Concerns Over Studies on Follow-on Biologics

Disposables simplify the flow of people and materials through a facility, decreasing both its footprint and amount of equipment needed, as well as minimizing upfront capital costs.

Biopharm turns plastic

While single-use technologies can be used for filtration, storage and at connection points in egg-based vaccine production, their use multiplies in cell-based applications.

Improving speed and quality in vaccine production

Princeton, NJ (Feb. 15, 2007)-Ranbaxy Inc., confirmed that federal officials conducted a search of its New Jersey offices on Feb. 14, 2007 and commented on its reported plan to acquire Merck's generics business.

Ranbaxy Comments on Merck KGaA Generics Rumors, Confirms Federal Raid in NJ

Geneva, Switzerland (Feb. 16)-During a two-day meeting, the World Health Organzation announced ?encouraging progress? in the development of a pandemic influenza vaccine but admitted that the industry still ?lacks the manufacturing capacity to meet potential pandemic influenza vaccine demand.?